Literature DB >> 26231782

A 3-bp Deletion VK600-1E in the BRAF Gene Detected in a Young Woman with Papillary Thyroid Carcinoma.

S Dvorakova1, V Sykorova2, E Vaclavikova2, P Sykorova3, P Vlcek3, D Kodetova4, P Lastuvka5, J Betka5, M Mokrejs2, J Vcelak2, B Bendlova2.   

Abstract

Papillary thyroid cancer (PTC) derived from follicular cells is a frequent thyroid tumor. The incidence of this type of malignancy is still growing worldwide. Several major genetic causes are recognized to cause PTC-mutations in the BRAF and RAS genes or rearrangements with the RET proto-oncogene. The most common genetic change found in PTC is a V600E mutation in the BRAF gene presented in 36-69 % of all PTC cases. For routine purposes, several methods were developed to selectively detect only this mutation. However, these methods miss other mutations in the BRAF gene located elsewhere. We focused on the analysis of the exon 15 of the BRAF gene by next-generation sequencing. Here we report a three nucleotide deletion VK600-1E in one patient and present this finding in the context of 13 previously described PTC cases with this deletion. Our patient is the second youngest one among the reported cases. Clinical features of PTC patients with VK600-1E are summarized. For the future, it is important to evaluate genotype-phenotype characteristics of patients with rare BRAF mutations and to follow up them for years.

Entities:  

Keywords:  BRAF gene; Deletion; Papillary thyroid cancer; Rare mutation

Mesh:

Substances:

Year:  2015        PMID: 26231782     DOI: 10.1007/s12022-015-9387-2

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  27 in total

1.  A new BRAF gene mutation detected in a case of a solid variant of papillary thyroid carcinoma.

Authors:  Vítor Trovisco; Paula Soares; Ricardo Soares; João Magalhães; Pedro Sá-Couto; Manuel Sobrinho-Simões
Journal:  Hum Pathol       Date:  2005-06       Impact factor: 3.466

2.  Flexible, scalable, and efficient targeted resequencing on a benchtop sequencer for variant detection in clinical practice.

Authors:  Kim De Leeneer; Jan Hellemans; Wouter Steyaert; Steve Lefever; Inge Vereecke; Eveline Debals; Brecht Crombez; Machteld Baetens; Mattias Van Heetvelde; Frauke Coppieters; Jo Vandesompele; Annelies De Jaegher; Elfride De Baere; Paul Coucke; Kathleen Claes
Journal:  Hum Mutat       Date:  2015-03       Impact factor: 4.878

3.  Association between BRAF V600E mutation and recurrence of papillary thyroid cancer.

Authors:  Mingzhao Xing; Ali S Alzahrani; Kathryn A Carson; Young Kee Shong; Tae Yong Kim; David Viola; Rossella Elisei; Bela Bendlová; Linwah Yip; Caterina Mian; Federica Vianello; R Michael Tuttle; Eyal Robenshtok; James A Fagin; Efisio Puxeddu; Laura Fugazzola; Agnieszka Czarniecka; Barbara Jarzab; Christine J O'Neill; Mark S Sywak; Alfred K Lam; Garcilaso Riesco-Eizaguirre; Pilar Santisteban; Hirotaka Nakayama; Roderick Clifton-Bligh; Giovanni Tallini; Elizabeth H Holt; Vlasta Sýkorová
Journal:  J Clin Oncol       Date:  2014-10-20       Impact factor: 44.544

4.  Integrated genomic characterization of papillary thyroid carcinoma.

Authors: 
Journal:  Cell       Date:  2014-10-23       Impact factor: 41.582

5.  Whole-exome sequencing of pancreatic neoplasms with acinar differentiation.

Authors:  Yuchen Jiao; Raluca Yonescu; G Johan A Offerhaus; David S Klimstra; Anirban Maitra; James R Eshleman; James G Herman; Weijie Poh; Lorraine Pelosof; Christopher L Wolfgang; Bert Vogelstein; Kenneth W Kinzler; Ralph H Hruban; Nickolas Papadopoulos; Laura D Wood
Journal:  J Pathol       Date:  2014-03       Impact factor: 7.996

6.  Prevalence, tumorigenic role, and biochemical implications of rare BRAF alterations.

Authors:  Susi Barollo; Raffaele Pezzani; Andrea Cristiani; Marco Redaelli; Laura Zambonin; Beatrice Rubin; Loris Bertazza; Mariangela Zane; Carla Mucignat-Caretta; Alessandro Bulfone; Gianmaria Pennelli; Eric Casal Ide; Maria Rosa Pelizzo; Franco Mantero; Stefano Moro; Caterina Mian
Journal:  Thyroid       Date:  2014-01-23       Impact factor: 6.568

Review 7.  BRAF mutation in papillary thyroid cancer: pathogenic role, molecular bases, and clinical implications.

Authors:  Mingzhao Xing
Journal:  Endocr Rev       Date:  2007-10-16       Impact factor: 19.871

8.  Deletion mutation of BRAF in a serrated adenoma from a patient with familial adenomatous polyposis.

Authors:  Eui Jin Lee; Cheol Keun Park; Jong-Won Kim; Dong Kyung Chang; Kyoung-Mee Kim
Journal:  APMIS       Date:  2007-08       Impact factor: 3.205

9.  Identification of a rare 3 bp BRAF gene deletion in a thyroid nodule by mutant enrichment with 3'-modified oligonucleotides polymerase chain reaction.

Authors:  Mi-Ae Jang; Seung-Tae Lee; Young Lyun Oh; Sun Wook Kim; Jae Hoon Chung; Chang-Seok Ki; Jong-Won Kim
Journal:  Ann Lab Med       Date:  2012-04-18       Impact factor: 3.464

10.  Cytological and molecular diagnosis of solid variant of papillary thyroid carcinoma: a case report.

Authors:  Giancarlo Troncone; Maria Russo; Umberto Malapelle; Marina Accardo; Angelo Ferraro; Immacolata Cozzolino; Lucio Palombini
Journal:  Cytojournal       Date:  2008-03-19       Impact factor: 2.091

View more
  1 in total

1.  Somatic genetic alterations in a large cohort of pediatric thyroid nodules.

Authors:  Barbora Pekova; Sarka Dvorakova; Vlasta Sykorova; Gabriela Vacinova; Eliska Vaclavikova; Jitka Moravcova; Rami Katra; Petr Vlcek; Pavla Sykorova; Daniela Kodetova; Josef Vcelak; Bela Bendlova
Journal:  Endocr Connect       Date:  2019-06       Impact factor: 3.335

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.